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Abstract
The COVID-19 pandemic (SARS-CoV-2 virus) is the defying global health crisis of our time. The absence of
mass testing and the relevant presence of asymptomatic individuals causes the available data of the COVID-
19 pandemic in Brazil to be largely under-reported regarding the number of infected individuals and deaths.
We propose an adapted Susceptible-Infected-Recovered (SIR) model which explicitly incorporates the under-
reporting and the response of the population to public policies (such as confinement measures, widespread
use of masks, etc) to cast short-term and long-term predictions. Large amounts of uncertainty could provide
misleading models and predictions. In this paper, we discuss the role of uncertainty in these prediction,
which is illustrated regarding three key aspects. First, assuming that the number of infected individuals
is under-reported, we demonstrate an anticipation regarding the peak of infection. Furthermore, while a
model with a single class of infected individuals yields forecasts with increased peaks, a model that considers
both symptomatic and asymptomatic infected individuals suggests a decrease of the peak of symptomatic.
Second, considering that the actual amount of deaths is larger than what is being register, then demonstrate
the increase of the mortality rates. Third, when consider generally under-reported data, we demonstrate
how the transmission and recovery rate model parameters change qualitatively and quantitatively. We also
investigate the effect of the “COVID-19 under-reporting tripod”, i.e. the under-reporting in terms of infected
individuals, of deaths and the true mortality rate. If two of these factors are known, the remainder can
be inferred, as long as proportions are kept constant. The proposed approach allows one to determine the
margins of uncertainty by assessments on the observed and true mortality rates.
Keywords: COVID-19, Under-reporting, SIR Model, Uncertainty, Brazil.
1. Introduction
The COVID-19 pandemic is definitely the global crisis of our time. A Chinese scientist first identified
the SARS-CoV-2 virus in humans in Wuhan, in the province of Hubei, China by December 2019. This virus
causes severe acute respiratory syndromes which can become potentially fatal. By the end of June, the
World Healthy Organization (WHO) estimated that the number confirmed cases was already reaching the
order 10, 000, 000, with over 490, 000 confirmed deaths.
Much more than presenting drastic effects on health systems, social and economical backlashes are
already felt by many countries; this is especially evident in countries with larger social inequalities, such as
Email addresses: marcelomnzm@gmail.com (Marcelo M. Morato), danielcajueiro@unb.br (Daniel O. Cajueiro),
julio.normey@ufsc.br (Julio E. Normey-Rico)
Preprint submitted to Alexandria Engineering Journal June 30, 2020
ar
X
iv
:2
00
6.
15
26
8v
1 
 [q
-b
io.
PE
]  
27
 Ju
n 2
02
0
Brazil. The effects of the virus on populations with poorer access to health systems and sanitation facilities
are strikingly harder (Kabir et al., 2020; San Lau et al., 2020; Khachfe et al., 2020). The city of Sa˜o Paulo
shows a very illustrative example of these differences: the city hall released a technical note by the end of
April1 stating that the observed mortality rate is 10 times larger in neighborhoods of the city with worse
social conditions and precarious housing.
In this paper, we consider the Brazilian COVID-19 pandemic context, as detailed by Werneck & Carvalho
(2020). Brazil is currently facing many issues due to the SARS-CoV-2 contagion, such as the advance of
the virus to farthest western cities, away from urban areas, where medical care is somehow less present.
The country has 26 federated states, which have been choosing different social distancing measures since
mid-March2. Even though a strong public health system is available in Brazil, many states have been
exhibiting near-collapsing conditions since May, with over 95 % of Intense Care Unit (ICU) hospital beds
occupied with COVID-19 patients (Brazilian Federal Medicine Council, 2020). Furthermore, we note that
the SARS-CoV-2 is currently posing great threat to indigenous communities, such as the Yanomami and
Ye’kwana ethnicities3. Clearly, the situation is border-lining.
The first official death due to the SARS-CoV-2 virus in Brazil was registered in March 17, while the first
case was officially notified in February 26. Through inferential statistics, Delatorre et al. (2020) acknowledge
the fact that community transmission has been ongoing in the state of Sa˜o Paulo since the beginning of
February (over one month before the first official reports). This points to empirical evidence that the true
amount of infected individuals, and possibly registered deaths, are actually very under-reported.
Due to absence of mass testing, Brazil is currently only accounting for COVID-19 patients with moderate
to severe symptoms4. People with mild or no symptoms are not being accounted for, since, in the beginning
of the pandemic, the Ministry of Health oriented to stay home and not to seek medical help if one only
displayed mild symptoms. Added to this fact, the SARS-CoV-2 virus shows itself as an asymptomatic
contagion for a large number of individuals. For these reasons, the scientific community has been warning
for a possibly huge margins of underestimated cases in Brazil (Silva et al., 2020; Rocha Filho et al., 2020;
Delatorre et al., 2020). Some studies, such as EPICOVID19 (2020a), point out to the presence of over 700 %
of under-reported cases. Furthermore, the daily reports (“datasets”) disclosed by the Brazilian Ministry
of Health5, only give an impression of the virus contagion in the past, since, in average, a person exhibits
acute symptoms only 20 days of the moment of infection. Through statistical procedures, Paixo et al. (2020)
have recently confirmed the empirical evidences that the margin of under-reported cases is quite large in the
majority of Brazilian states. The state of Sa˜o Paulo seems to be the one with less uncertainty regarding the
number of deaths, because the data also partially incorporates those deceased due to severe acute respiratory
syndromes even without COVID-19 testing.
Therefore, it seems evident that to account for uncertainty is essential to formulate adequate public
health policies to address the SARS-CoV-2 virus spread. With respect to this context, this paper intends
to model the role of uncertainty in this pandemic in such way that decision makers are able to plan more
coherent, and adherent to reality, policies. It is worth mentioning that propositions to address the pandemic
through recurrent social isolation periods has been recently assessed through optimal control in (Morato
et al., 2020).
Table 1 summarizes the estimates available in the literature regarding the under-reporting levels and
true mortality rates for Brazil. In this Table, we evidence the percentage increase of under-reports w.r.t.
to reported deaths and cases, as evaluated by prior studies. Most of these works show that, in average,
1Secretaria Municipal da Sau´de de Sa˜o Paulo. Boletim Quinzenal Covid-19. April 30, 2020. Available at: https:
//www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/PMSP_SMS_COVID19_Boletim%20Quinzenal_20200430.pdf.
2Throughout this paper, the Year/Month/Day notation is used.
3The Brazilian Socioenvironmental Institute (ISA, Instituto Socioambiental, see https://www.socioambiental.org/en) has
released a technical note Ferrante & Fearnside (2020) which warns for the contagion of COVID-19 of up to 40 % of Yanomami
Indigenous Lands, amid the states of Amazonas and Roraima and a long the border between Brazil and Venezuela, due to
the presence of approximately 20000 illegal mining prospectors. Datasets regarding the COVID-19 spread amid indigenous
communities are available in https://covid19.socioambiental.org.
4As well as those deceased due to the SARS-CoV-2 virus.
5These datasets comprise the number of infected and deceased patients at the given day.
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Infected Deaths True
Source Reported × more Reported × more mortality rate
(Alves et al., 2020;
Gaete, 2020)
6.55% 14.2 100% 0 1.08% to 1.11%
(Prado et al., 2020) 7.8% to 8.1% 11.8 to 12.3 100% 0 1.3%
(Observato´rio Covid-
19 BR, 2020)
26.9% to 37.5% 1.67 to 2.72
(Globo, 2020) 85.5% 0.17
(UOL, 2020) 67.5% 0.48
(EPICOVID19, 2020c) 10% (5.9% to 20%) 9 (4 to 16) 0.42% (0.23% to 0.87%)
(EPICOVID19, 2020b) 25% (13.9% to 41.7%) 3 (1.4 to 6.2) 0.97% (0.84% to 1.12%)
(EPICOVID19, 2020a) 12.5% 7
(COVID-19 Brasil Re-
search Team)
7.4% 12.5
Table 1: Estimates of COVID-19 sub-report levels in Brazil and true mortality rates.
the number of infected individuals could be 3 to 14 times higher. Some studies from other countries point
out that this number could reach up to 306. According to technical news-pieces disclosed by UOL (2020)
and Globo (2020), the amount of under-reports in terms of deaths due to the SARS-CoV-2 virus ranges
from 17% to 122%. Alves et al. (2020) and Gaete (2020) estimate the real mortality rate estimated for
Brazil to be approximately 1.08% to 1.11%, but estimates from the research group EPICOVID19 (2020c,b)
from random samples of the Brazilian population point out that this mortality could be ranging from 0.42%
to 0.97%. Studies from other countries, such as Khan (2020) and Baud et al. (2020) show that this true
mortality rate varies roughly from 1 to 5%, but (Mallapaty, 2020) states that recent research are converging
to the estimation of the true mortality rate to be between 0.5 to 1%. (Perez-Saez et al., 2020) find the true
mortality rate to be approximately 0.64% for Geneva, Switzerland.
Bearing in mind the previous discussion, the main motivation of this paper is to present an adapted
Susceptible-Infected-Recovered (SIR) model which inherently takes into account these uncertainty levels,
considering the Brazilian COVID-19 context. Furthermore, the motivation is also to assess the role of un-
certainty in the predictions cast with such models. We denote uncertainty as the amount of sub-notification
with respect to infected and deceased individuals. Our approach comprises the following ingredients:
• Firstly, we propose a new modelling scheme that incorporates a dynamic decaying parameter for the
viral transmission rate. The dynamic decaying parameter for the transmission rate, adapted from
Morato et al. (2020), considers that the government applies contagion mitigation measures (such as
social isolation and incentives to use masks, which we refer as “pandemic policies” henceforth), which
decreases the contagion spread dynamics.
• Secondly, we develop an uncertainty measure with respect to infected and deceased individuals. The
uncertainty is embedded to the optimization procedures used to determine the epidemiological param-
eters, in order to correct underestimates of infected and deceased individuals.
• Thirdly, we use this adapted SIR models to make predictions for the Brazilian scenario regarding
several different uncertainty sets, with short and long term forecast spans. By this, we are able to
illustrate the role of under-reporting in the model response curves. Specifically, we study its effect
upon peak of infections (in terms of amplitude and time shift), upon the total number of deaths,
observed mortality rate, and model epidemiological parameters.
6Naomi Martin. Mass. official coronavirus count is 218, but experts say true number could be as
high as 6,500. The Boston Globe. March 17, 2020. Available at: https://www.bostonglobe.com/2020/03/17/metro/
mass-official-coronavirus-count-is-197-experts-say-true-number-could-now-be-high-6000/.
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Figure 1: Cumulative number of infected.
• Finally, considering the uncertainty tripod, i.e. the strong link between under-reporting of infected
and deaths and the true mortality rate, we extrapolate and suggest an alignment of the observed and
the true mortality rate to infer on the level of uncertainty present on the measurements.
We note that this paper relates to a previous paper by the Authors (Bastos & Cajueiro, 2020), wherein
SIR-like models present short and long term outlooks for Brazil. The previous work covered only the
data from an early stage of the contagion, until March 30, 2020. Furthermore, the Authors used parametric
variations of the parameters to introduce the uncertainty in the identified model, differing from the approach
proposed herein.
Figure 1 shows the SIR model forecasts back in March 17, with respect to real data, considering variations
for the transmission parameter β. We note that parametrically changing the transmission parameter is not
enough to make the model fit to the real data. Therefore, a time-varying parameter is added to model the
effect of pandemic policies, which meddle with the viral transmission rates. Such adapted model is able
to account for the population response to governmental enacted policies. In practice, the pandemic policy
can be understood as a feedback of endogenous variables, also depending non-observed time-varying factors
(people can simply decide to relax quarantine measures, even if the a social isolation policy is still enacted).
Through our simulations, we are able to replicate the real data with a fair amount of similarity, as shown
in the sequel.
We organize this paper as follows. Section 2 presents the proposed SIR-adapted epidemiological model,
which incorporates a new dynamic variable that describes the response of the population to enacted pandemic
policies. In this section, we also discuss uncertainty modelling, in terms of the available datasets. Section
3 details the parameter estimation procedure, which inherently includes uncertainty. Section 4 shows the
results in terms of parameter estimation and forecasts for the COVID-19 pandemic in Brazil. We present a
through discussion on the achieved results and concluding remarks in Section 5.
2. SIR Epidemiological Models
Recent literature (Peng et al., 2020; Kucharski et al., 2020b) has demonstrated how the the infection
rate and evolution dynamics of the SARS-CoV-2 virus can be adequately described by Susceptible-Infected-
Recovered kind models. In this Section, we present the classical SIR model due to Kermack & McKendrick
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(1927), the new dynamic variable which models the population’s response to isolation policies (enacted by
local governments) and discuss some remarks on data uncertainty.
2.1. Epidemiological model
The SIR describes the spread of a given disease with respect to a population split into three non-
intersecting classes, which stand for:
• The total amount of susceptible individuals, that are prone to contract the disease at a given moment
of time t, denoted through the dynamic variable S(t);
• The individuals that are currently infected with the disease (active infections at a given moment of
time t), denoted through the dynamic variable I(t);
• The total amount of recovered individuals, that have already recovered from the disease, from an initial
time instant 0 until the current time t, denoted through the dynamic variable R(t)
Due to the evolution of the spread of the disease, the size of each of these classes change over time and the
total population size N is the sum of these three classes, as follows:
N(t) = S(t) + I(t) +R(t) . (1)
In the SIR model, the parameter β stands for the average number of contacts that are sufficient for
transmission of the virus from one individual, per unit of time t. Therefore, βI(t)/N(t) determines the
average number of contacts that are sufficient for transmission from infected individuals, per unit of time,
to one susceptible individual; and (βI(t)/N(t))S(t) determines the number of new cases per unit of time
due to the amount of S(t) susceptible individuals (they are “available for infection”).
Furthermore, the parameter γ stands for the recovery rate, which is the rate that each infected individual
recovers (or dies). This parameter characterizes the amount of individuals that “leaves” the infected class,
considering a constant probability quota per unit of time. We model the amount of deceased individuals
due to a SARS-CoV-2 infection following the lines of (Keeling & Rohani, 2011), where D(t) is the dynamic
variable which describes the amount of deaths and ρ is the observed mortality rate.
The “SIRD” (Susceptible-Infected-Recovered-Dead) model is expressed as follows:
dS(t)
dt
= −(1− ψ(t))βI(t)S(t)
N(t)
dI(t)
dt
= (1− ψ(t))βI(t)S(t)
N(t)
− γI(t)
1− ρ
dR(t)
dt
= γI(t)
dD(t)
dt
=
ρ
1− ργI(t)
[SIRD] (2)
In this model, ψ represents a transmission rate mitigation factor7: for ψ = 0, there is ”no control” of
the viral spread, while for ψ = 1, the contagion is completely controlled, with no more social interactions (a
complete lockdown of all population would represent this scenario). It holds that N(t) = N0 −D(t), where
N0 is the initial population size. Remark that, in SIR kind models, I(t) represents the active infections at
a given moment, while D(t) represents the total amount of deaths until this given moment; for this reason,
it follows that dD(t)dt is proportionally dependent to I(t).
7We note, with respect to previous works (Morato et al., 2020; Bastos & Cajueiro, 2020), that the ψ parameter used in this
work represents for 1− ψ in the prior. We believe the current representation is easier to grasp.
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Since the SIR model is used herein to describe a short-term pandemic outbreak, we do not consider the
effects of demographic variations. Despite recent discussion regarding the possibilities of reinfection (Del Rio
& Malani, 2020), we assume that a recovered individual does not contract the disease twice in the short
period of time of this pandemic.
Since, in the case of the SARS-CoV-2 virus, there is a relevant percentage of the infected individuals that
are asymptomatic, we progress by splitting the class of infected individuals into the classes of symptomatic
(IS) and asymptomatic individuals (IA), as suggested by (Robinson & Stilianakis, 2013; Arino et al., 2008;
Longini-Jr. et al., 2004). This yields the “SIRASD” model8:
dS
dt
= −(1− ψ)(βAIA(t) + βSIS(t)) S
N(t)
dIA(t)
dt
= (1− ψ)(1− p)(βAIA(t) + βSIS(t)) S
N(t)
− γAIA(t)
dIS(t)
dt
= (1− ψ)p(βAIA(t) + βSIS(t)) S
N(t)
− γSIS(t)− ρS
1− ρS γSIS(t)
dRA(t)
dt
= γAIA(t)
dRS(t)
dt
= γSIS(t)
dD(t)
dt
=
ρS
1− ρS γSIS(t)
[SIRASD] (3)
In this model, ρS denotes the actual observed mortality rate for the symptomatic class only, while ρ stands
for the total observed mortality rate (for both symptomatic and asymptomatic classes). The parameter p
is included to represent the percentage of infected individuals which present symptoms; (1− p) denotes the
percentage of those without symptoms.
Two important issues should be commented: i) the mortality for asymptomatic individuals is extremely
low; for simplicity it is taken as null in the SIRASD model; and ii) the observed (real) mortality rates also
includes those that died from the contagion while not being accounted for in the available data sets. This is,
if there is a number of sub-reported deaths, this number should also influence the mortality rate parameters.
One can evaluate the instantaneous values for the morality rates directly as follows:
ρS(t) =
D(t)
IS(t) +RS(t) +D(t)
(4)
ρ(t) =
D(t)
IA(t) +RA(t) + IS(t) +RS(t) +D(t)
(5)
Therefore, when the pandemic is over, it follows that ρS = lim
t→∞ ρS(t) = D(∞)/(RS(∞) + D(∞)) and
ρ = lim
t→∞ ρ(t) = D(∞)/(RA(∞) +RS(∞) +D(∞)). Due to this fact, it holds that
ρS
ρ
=
1
p
, i.e. ρ = p ρS .
To take into account the effect of public health policies (that are enacted by local governments to
“control” and mitigate the effects of the COVID-19 pandemic), such as social isolation, incentives to use of
masks, etc., we include the dynamic equation for ψ(t) to the SIRD and SIRASD models:
dψ(t)
dt
=
{
α(ψ∞ − ψ(t)) if under the pandemic policies effect,
0 otherwise.
(6)
Note that ψ(t) converges to ψ∞ with a settling time of 3α
9. It follows that ψ∞ is a factor which stands
for the maximal observed effect of pandemic policies. Note that for larger values of ψ∞ (closer to 1), the
8SIRASD stands for Susceptible-Infected-Recovered-Asymptomatic-Symptomatic-Deaths.
9Considering that ψ(t) = ψ∞(1− e−αt) and ψ∞ − ψτ
ψ∞
= e−ατ = δ ⇒ τ = − ln δ
α
, if δ = 0.05 then τ ≈ 3
α
.
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spread of the SARS-CoV-2 virus gets slower, with smaller peak of infections and number of deaths. The
condition of ψ = 1 represents a total isolation condition, where the amount of contacts is reduced to zero.
In the recent paper by the Authors (Morato et al., 2020), these new models were used to conceive model-
based optimal control policies, under a Predictive Control optimization formalism. Through the sequel, we
refer to these extended models (which embed the effect of public health policies) as SIRD+ψ and SIRASD+ψ
models, respectively.
2.2. Uncertainty Model
As discussed in the Introduction, the sub-notification regarding the number of infected and deceased
individuals, due to COVID-19, has been pointed out as rather elevated in Brazil, as brought to focus by
a number of recent papers (Bhatia et al., 2020; The Lancet, 2020; Silva et al., 2020; Rocha Filho et al.,
2020; Rodriguez-Morales et al., 2020; Morato et al., 2020). These studies discuss that the amount of under-
reported cases regarding infected individuals could be up to 30 times the reported values. Furthermore,
the sub-notification in terms of deaths due to the SARS-CoV-2 virus might be over 120 % the mortality
disclosed by the Ministry of Health.
Therefore, we proceed by modelling these uncertainty margins as follows:
IrealS (t) = I
measured
S (t) + I
unknown
S (t) , (7)
Dreal(t) = Dmeasured(t) +Dunknown(t) , (8)
where the super-index ”measured” denotes the values as prescribed by the Ministry of Health (data), ”un-
known” as the sub-notified values and ”real” for total value, including uncertainty.
It follows that the amount of uncertainty in any of these variables, generically referred to as X, can be
described by a concentrated multiplicative parameter, this is:
Xmeasured(t) = qXX
real(t)
Xunknown(t) = (1− qX)Xreal(t)
}
⇒ X
measured(t)
Xunknown(t)
=
qX
1− qX , (9)
with X representing either D or IS and qX denoting the respective uncertainty parameter. Such concentrated
parameter qj ∈ [0, 1] gives a measure for the amount of sub-notification. For instance, if we consider qD = 1,
it means that there is no sub-notification with respect to the disclosed datasets for the number of deaths.
For qD = 0.5, we observe that the actual number of deaths is twice the reported amount.
Using the same notation, through the sequel, we present our results using the following transformation,
for understanding simplicity:
q˜X =
1
qX
− 1 , (10)
which holds for Xunknown(t) = q˜XX
measured(t) ⇒ Xreal(t) = (1 + q˜X)Xmeasured(t). This notation con-
catenates the following idea: as an example, if we consider q˜I = 0, it means that the reported amount of
infections is equal to the real amount. Consequently, for q˜I = 0.25, for instance, it means that the real
amount of infections is 25% bigger than the number reported cases.
With respect to the way we model uncertainty, we must stress that this paper is concerned with the
exposure of the simulation/prediction phenomena when using uncertainty-embedded identification applied
to SIR-like models in order to forecast the COVID-19 pandemic dynamics in Brazil. The discussion resides
in the following key points:
(a) the influence of uncertainty in these forecasts;
(b) the temporal shift of the peak of infections according to the level of uncertainty (which would also
impact directly in the enacted pandemic policies);
(c) the temporal aspect of the mortality rate;
(d) the under-reporting tripod.
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Furthermore, we must emphasize that the prediction for the amount of deaths can be quite equivocate
according to the level of uncertainty that is considered, since the parameters qD and qI directly meddle with
the ”D” output of the SIRASD+ψ model. It seems reasonable that as time progresses and the pandemic
contagion gets ”controlled” (i.e. stabilizes), the amount of uncertainty tends to decrease. Anyhow, we must
assure that the previewed phenomena will irrevocably take place (the peak of infections and a possible
second peak), if the enacted pandemic policies remain the same.
3. Estimation procedure
The Brazilian Ministry of Health provides (daily) two useful data time-series which are used to evaluate
(i.e. identify) the SIR model parameters: i) the total number of infected individuals, denoted
Itotal(t) = I(t) +R(t) +D(t)
and ii) the total number of deaths, which is D(t). In this paper, we use data from February 25, 2020, to
May 31, 2020.
Parameters β, γ and ρ are computed according to the procedure adapted from Bastos & Cajueiro (2020),
considering that the period for which pandemic policies had not yet been formally implemented (this period
comprises the weeks from February 25, 2020 until March 22, 2020). We find that the recovery rate γ is
found to be roughly constant at 0.150876, which is consistent with other findings in the literature (Read
et al., 2020; Nishiura et al., 2020). We maintain this value for γ throughout the following identification
steps. Note that this parameters is inherent to the disease and time-invariant.
In order to estimate the parameters of the SIRD+ψ and SIRASD+ψ models, considering the remainder
of the available data (from March 22, 202 onward), we proceed by performing a Least-Squares identification
procedure, with respect to different levels of uncertainty (q˜D and q˜I). These uncertainty levels are directly
embedded to the datasets prior to the actual identification. Minimizing the square-error between the in-
tegrated variables and their real values is in accordance with regular identification methodologies (Bard,
1974; Brauer et al., 2019). Then, we proceed by following an hierarchical procedure, as done in Bastos
& Cajueiro (2020): firstly, we estimate parameters of the SIRD model, then, assuming that the infected
individuals in the SIRD model are the symptomatic individuals in the SIRASD model, we estimate the
remaining parameters of the SIRASD model.
Our identification procedure also includes constraints 10 to the possible parameter values: β, βS , βA ∈
[1/20, 2], γ, γS , γA ∈ [1/14, 1/2], ρ, ρS ∈ [0.001, 0.2], α ∈ [0, 1] and ψ∞ ∈ [0.0, 1.0]. These limits are in
accordance with those presented by Werneck & Carvalho (2020) and Bastos & Cajueiro (2020).
Globally, the identification procedure for the SIRD+ψ model resides in solving the following minimization
problem:
min
β,ρ,α,ψ∞
1
2
∑
t
(L2I + L2D) (11)
LI = log
[
1 +
(
Itotal(t)−D(t)/qD
qI
)
1
Imax
]
− log
(
1 +
Iˆ(t) + Rˆ(t)
Imax
)
(12)
LD = log
[
1 +
(
D(t)
qD
)
1
Dmax
]
− log
(
1 +
Dˆ(t)
Dmax
)
(13)
where Iˆ(t), Rˆ(t) and Dˆ(t) are estimated values of the infected, recovered and deaths, respectively, and
Imax = max
t
(
Itotal(t)−D(t)/qD
qI
)
, Dmax = max
t
(
D(t)
qD
)
. We decided to normalize the each series by its
10If more restrictive bounds are used, we mention them explicitly.
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maximum value and take the logarithm as an approach to balance different exponential characteristics of
the infected and deaths series. The initial conditions for the identification procedures are D0 = D(0)/qD,
I(0) = Icum(0) − D(0), R(0) = 0, S(0) = N0 − I(0) − R(0) − D(0), where N0 = 210147125 is the initial
population according to Brazilian Institute of Geography and Statistics (IBGE). We estimate α and ψ∞
only in the simulation without any uncertainty, and use these values on the other minimization procedures
because we believe that these parameters (a response of the society) should be the same, regardless of the
uncertainty level.
Equivalently, the identification procedure for the SIRASD+ψ follows through the minimization problem
below:
min
βA,γA,ρ
1
2
∑
t
(L2IS + L2D) (14)
LIS = log
[
1 +
(
Itotal(t)−D(t)/qD
qI
)
1
Imax
]
− log
(
1 +
IˆS(t) + RˆS(t)
Imax
)
(15)
where IˆS(t) and RˆS(t) are estimated values of the symptomatic infected and recovered, respectively, and the
initial conditions are D(0) = D(0)/qD, IS(0) = I
cum(0)−D(0), IA(0) = IS(0)(1− qI)/qI , RS(0) = RA(0) =
0, S(0) = N0−D(0)− IS(0)− IA(0)−RS(0)−RA(0). For this model, we begin the identification procedure
with βS = β, γS = γ, where β and γ are the values directly taken from the identification procedure regarding
the SIRD + ψ. Hence, we denote the procedure as hierarchical.
We stress, once again, that a large number of different SIRD+ψ and SIRASD+ψ models are obtained
through the identification procedures detailed in the prequel. Each one of these models is identified for
different level of uncertainty (qD and qI).
4. Results
In this Section, we present the main results of our paper, which comprise the role that sub-notification
uncertainty plays in the model-based predictions of the COVID-19 contagion, harshly affecting the outlooks
for its evolution spread in Brazil. To have the available data with such large amounts of uncertainty is a very
troublesome issue, since public health policies are currently derived through the available datasets, meaning
that these policies may be equivocate, such as reducing social isolation policies before adequate time, and
thus lead to possibly unwanted phenomena.
The following results comprise predicted forecasts with the SIRD+ψ and SIRASD+ψ models; they have
been obtained using Python software.
4.1. SIRD+ψ model
We begin by depicting the results achieved with the SIRD+ψ model.
Figure 2 shows the estimation of the ψ(t) variable, which models the population’s response to pandemic
policies using Eq. (6), considering no uncertainty (qI = qD = 1, only for the moment). In this Figure,
the orange dots represents the identification results found directly through the SIRD model, as if ψ was a
parameter estimated for each sample. The solid blue line represents the time-varying ψ(t) curve. Evidently,
we can notice that the estimation of the proposed ψ(t) model absorbs a great deal of error. Consequently,
the forecasts derived from such models (SIRD+ψ, SIRASD+ψ) can vary quite significantly from one day to
the next (considering the identification procedure performed daily), while the main trend is followed. Some
recent studies Morato et al. (2020); Kucharski et al. (2020a) discuss that the re-estimation (re-identification)
should be performed each week, in such way that these daily errors get dynamically absorbed and are thus
represented through the mean behaviour. We must re-stress that the following forecasts are extremely
sensible to the available datasets (and to the uncertainties) and, thus, to re-perform the identification as
time progresses is essential. This is: one cannot use the derived models as if their parameters would not
change along time. The forecasts only offer qualitative insights.
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Figure 2: Estimation of ψ(t) for the SIRD+ψ model using the data provided by the Ministry of Health (q˜I = q˜D = 0), which
we get α = 0.186353 and ψinfty = 0.494027.
We consider several different values for the uncertainty parameters q˘I and q˘D in the following simulation
runs11. Anyhow, for exhibition lightness purposes, we will only explicitly explore the ones that found to be
more likely scenarios for Brazil (coherent with prior discussion in the literature). Our baseline uncertainty
parameters are q˜I = q˜D = 0 (nominal condition), corresponding to the Ministry of Health datasets. We
explore q˜I ∈ {7, 14, 30} and q˜D ∈ {0.25, 0.5, 1}, in consonance with previous references. These uncertainty
margins relate to the percentage increase regarding infections and deaths, respectively. The gray area
presented in the short and long term predictions correspond to uncertainty over the region {(q˜I , q˜D)|q˜I ∈
[0, 30] and q˜D ∈ [0, 1]}.
Based on these uncertainty values, we simulate the SIRD+ψ model along time. We show short and
long-term perspectives in Figures 3 and 4. Detailed values that arise in these simulations are concatenated
in Table 2. With respect to these Figures, we remark the following key points:
1. The long-term forecast of the infected cases suggests that greater uncertainty of the number of infected
has the effect of anticipating the peak in time and also increase its amplitude. That is, if we have 7,
14 and 30 times more infected, then the peak in September 4 will be anticipated to July 28, 17 and
4, respectively, and also the peak amplitude will increase from 3.9% to approximately 4.6%, 4.7% and
4.8%, respectively. We note that this peak percentage is given w.r.t. to the total population size.
2. The peak of infections gets shifted for at least one month for larger uncertainties. This could be
quite troublesome, since public health policies concerning ICU beds, for instance, may be accounting
for erroneous data and hospitals may be surprised by a larger demand of ICUs than what is expected
when disregarding uncertainties. Further analysis are necessary since we cannot separate who are
asymptomatic from the ones that are symptomatic and, therefore, would actually demand health care.
11To ease the Reader’s interpretation, we transformed qI and qD in q˜I and q˜D, respectively, by the use of the transformation
in Eq. (10).
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Figure 3: Short-term simulation for the SIRD+ψ model using different values of uncertainty.
3. The amplitude of the peak of infections shows small variations, despite uncertainties. This suggests
that the SARS-CoV-2 will infect the same amount of people. Moreover, the virus does not distinguish
between asymptomatic or symptomatic individuals, only aiming to spread its genetic material.
4. The mortality rate obtained from the Brazilian Ministry of Health datasets does not reflect reality
because it differs significantly from the true mortality rate (see Table 1). The long-term deaths forecast
suggests that the number of infected uncertainty drastically decreases the true mortality rate, while
increases in the deaths uncertainty increase the true mortality rate.
We proceed by exploring how the infected uncertainty influences the mortality rate for a given death
uncertainty level, as shows Figure 5. In this Figure, we present the estimated values for the mortality rate
(ρ) from Eq. (2) as a function of the infected uncertainty (q˜I) for a given (fixed) death uncertainty (q˜D)
amount. The values used in this graph and some estimated epidemiological parameters are in Tables 4 and
q˜D q˜I ρ Peak (%) Peak Forecast Number of Deaths
0 0 8.8569% 3.9405% September 4, 2020 9,226,000
0 7 1.2086% 4.6651% July 28, 2020 1,316,778
0 14 0.6447% 4.7508% July 17, 2020 706,295
0 30 0.3090% 4.8573% July 4, 2020 341,003
0.5 7 1.8597% 4.5681% July 29, 2020 2,012,722
0.5 14 0.9958% 4.6793% July 18, 2020 1,085,310
0.5 30 0.4785% 4.7992% July 5, 2020 525,776
1 7 2.5450% 4.4673% July 30, 2020 2,735,068
1 14 1.3683% 4.6049% July 18, 2020 1,483,225
1 30 0.6594% 4.7390% July 5, 2020 721,160
Table 2: Observed mortality, peak percentage and its respective date of occurrence and number of deaths after 360 days for
the SIRD+ψ model for different values of uncertainty.
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Figure 4: Long-term simulation for the SIRD+ψ model using different values of uncertainty.
6 in Appendix 6.1. We must stress that the observed mortality rate decreases with respect to the increase
of infected uncertainty q˜I ; this is shown directly in Figure 5. The reason for this phenomenon resides in
the fact that more uncertainty over the infected individuals, while keeping the number of deaths constant,
implies that the mortality rate will decrease - see Eq. (5).
Figure 6 provides the uncertainty paths for infected and deaths considering specific mortality rates.
4.2. SIRASD+ψ model
With respect to the uncertainty-embedded identification procedure in Section 3, Figures 7 and 8 show,
respectively, short and long term predictions using the SIRASD+ψ model. Table 3 collects the essential
information of these forecasts. Regarding the long-term forecast, we call attention to the infected cases. An
increase in the infected uncertainty anticipates the peak in time, just as in the SIRD+ψ model, but the
symptomatic peak amplitude decreases.
With respect to the simulated mortality rate, Figure 9 shows the relationship between ρ and the uncer-
tainties qD and qI ; these values are detailed in Table 5 of Appendix 6.1. Results differ only slightly from
those obtained with the SIRD+ψ model and, thus, the same conclusions can be inferred. Furthermore,
Figure 10 gives an insight on the possible “trajectories” of ρ with respect to these uncertainty margins, i.e.
showing the static gain between qD, qI and ρ, for different levels of mortality.
The identified epidemiological parameters for the SIRASD+ψ model are presented in Table 7, in the
Appendix. There are two interesting phenomena regarding βA: (i) in all simulations we have βA > βS ,
meaning that asymptomatic individuals are more likely to transmit the disease since they probably do not
know they are infected; and (ii) increasing the infected uncertainty causes a decrease in the parameter βA,
meaning that the probability to transmit the disease also decreases. As for γA, we notice that: (i) it is greater
than γS in all cases, meaning that asymptomatic individuals have a smaller infectious period (1/γA); and
(ii) it decreases as the infected uncertainty increases, meaning that the average infectious period increases
with the increases of asymptomatic individuals, i.e. it is more likely to find more asymptomatic individuals
spreading the disease for a longer period.
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Figure 5: The number of times more infected than reported (q˜I) vs. the observed mortality rate (ρ) for the SIRD+ψ model.
The blue, orange and green curves represent simulations using data from the Ministry of Health (q˜D = 0), 50% more deaths
(q˜D = 0.5) and 100% more deaths (q˜D = 1).
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Figure 6: Mortality rate paths using the number of times more infected than reported (q˜I) versus the number of times more
deaths than reported (q˜D) for the SIRD+ψ model.
We must point out that analogous results to those achieved with the SIRD+ψ model are found, as
expected due to the equivalence between the nonlinear differential equations of these two models. We stress
some key points:
• An increase on the sub-notification with respect to infected individuals directly implies in the reduction
of the peak of symptomatic infections: essentially, the virus “does not care” if it causes symptoms or
not on the infected individual (its only goal is to infect and replicate);
• Assuming that the virus infects the same amount of people (despite the margins of the sub-reports),
and as it infects (faster) more individuals without causing symptoms, we observe a smaller percentage
peak of symptomatic infections for larger sub-notification.
• The uncertainty margins upon the infected (qI) and the death count (qD) influence both infected and
death curves, I(t) and D(t), respectively. The infected curve is directly and mostly influenced by the
infected uncertainty, but the death uncertainty affects this curve more modestly through the total
number of the population, N(t), on the transmission channel (see Eq. (2) and Figure 4). Additionally,
we emphasize that the deaths curve also depends on both uncertainty parameters, qD and qI . The
smallest death count forecast is found with an elevated under-reporting of asymptomatic infections
and a small sub-report margins regarding deaths. This fact seems empirically reasonable, once an
unaccounted increase on the number of deceased individuals should increase the number of deaths.
• The instantaneous mortality rates, as of Eqs. (4) and (5), are show in Figure 11. These instantaneous
values indeed converge to those presented in Table 3. Anyhow, it is imperious to recall that the mor-
tality rate, in practice, varies according to the amount of testing. Since the dynamics for symptomatic
and asymptomatic infections evolve differently along time, the mortality rate also depends on the stage
of the pandemic evolution. If the local epidemic scenario is an ending stage, the mortality rate tends
14
Figure 7: Short-term simulation for the SIRASD+ψ model using different values of uncertainty.
Both Symptomatic Asymptomatic
q˜D q˜I ρS ρ Peak (%) Peak Forecast Peak (%) Peak Forecast Peak (%) Peak Forecast Deaths
0 7 8.5408% 1.0676% 3.0667% 2020-07-31 0.3856% 2020-08-01 2.4267% 2020-07-31 939,784
0 14 8.5335% 0.5689% 4.2421% 2020-07-18 0.2149% 2020-07-18 2.7655% 2020-07-18 512,176
0 30 8.5208% 0.2749% 4.7137% 2020-07-03 0.1155% 2020-07-03 3.3167% 2020-07-03 262,242
0.25 7 10.6162% 1.3270% 3.0667% 2020-07-31 0.3791% 2020-08-01 2.4505% 2020-07-31 1,172,135
0.25 14 10.6073% 0.7072% 4.2421% 2020-07-18 0.2111% 2020-07-18 2.7858% 2020-07-18 638,423
0.25 30 10.5882% 0.3416% 4.7137% 2020-07-03 0.1130% 2020-07-03 3.3205% 2020-07-03 325,994
0.5 7 12.6686% 1.5836% 3.0761% 2020-07-31 0.3726% 2020-07-31 2.4751% 2020-07-31 1,403,689
0.5 14 12.6580% 0.8439% 4.2421% 2020-07-18 0.2073% 2020-07-18 2.8063% 2020-07-18 764,006
0.5 30 12.6358% 0.4076% 4.7117% 2020-07-03 0.1109% 2020-07-03 3.3414% 2020-07-03 390,023
1 7 16.7050% 2.0881% 3.0761% 2020-07-31 0.3596% 2020-07-31 2.5249% 2020-07-31 1,864,283
1 14 16.6919% 1.1128% 4.2494% 2020-07-18 0.1998% 2020-07-18 2.8485% 2020-07-18 1,013,367
1 30 16.6639% 0.5375% 4.7117% 2020-07-03 0.1068% 2020-07-03 3.3830% 2020-07-03 516,959
Table 3: Observed mortality (ρS and ρ), peak percentage and its respective date of occurrence and number of deaths after 360
days for the SIRD+ψ model for different values of uncertainty.
to increase and stabilize. Note that if the margins of uncertainty are known (or roughly estimated),
we can forecast quite accurately what will be the observed rates of mortality in the country.
• The real mortality rate, measured with population samples, can be quite misleading, since it shows
only an instantaneous snippet of the pandemic at a given moment (much like a ”photograph”). Figure
11 shows that the real mortality rate evolves in an asymptotic-like behaviour, converging to some
steady-state value. Therefore, if one computes the mortality rate of a sample population in country
with mass testing (unlike Brazil), and this country is not yet in an ending stage of its COVID-19
epidemic, one can observe values that are not the steady-state ones. In other words, there would still
be symptomatic and asymptomatic to-be individuals which would alter the real mortality rate. And,
as shows Figure 11, this real rate tends to be greater than in the beginning stages of the SARS-CoV-2
spread.
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Figure 8: Long-term simulation for the SIRASD+ψ model using different values of uncertainty.
5. Discussion and Conclusions
In this paper, we discussed the Brazilian COVID-19 pandemic scenario, the effects of under-reporting
regarding the number of infections and deaths due to the SARS-CoV-2 virus in the country. Through two
SIR-like adapted models, which include the population’s response to measures of control of the pandemic
(such as social isolation, the use of masks, etc.) and deaths due to the disease. Furthermore, we make a set
of possible forecasts and evaluate how uncertainty meddles with the COVID-19 pandemic prediction curves.
Specifically, we analysed how uncertainty affects the infection peak displacement in time and its amplitude,
epidemiological parameters, the observed and real mortality rate evolution, and how infection and deaths
uncertainty and the true mortality rate could be related.
We used two SIR-like models, SIRD+ψ and SIRASD+ψ, which differ in two aspects. First, the SIRD+ψ
model considers that asymptomatic and symptomatic parameters are equal, that is, βS = βA = β and γS =
γA = γ and that the mortality rate is applied in the whole infected population, while the SIRASD+ψ model
distinguishes symptomatic and asymptomatic parameters and applies the mortality rate to the symptomatic
only. Second, the initial condition of the SIRD+ψ model suggests that the infected class of individuals is
actually split as 100qI% symptomatic and 100(1 − qI)% asymptomatic, while the initial condition of the
SIRASD+ψ model considers that the proportion of one symptomatic per
(1− qI)
qI
asymptomatic individual
(as gives Eq. (9)).
It is a fact (and heavily discussed by recent literature) that the available datasets disclosed by the
Brazilian Ministry of Health have large sub-notification margins. Brazil currently conducts roughly 4000
tests per million inhabitants, which is one of the lowest rates in the world (Volpatto et al., 2020). Likewise,
the number of deaths may be underestimated for the same reason. According to (COVID-19 Brasil Research
Team), only 8 % of infections are reported; the real number of infected individuals are possibly up to 30
times bigger than what is being disclosed by the authorities (Scabini et al., 2020; Volpatto et al., 2020).
Herein, we have tried to expose some essential insights regarding sub-notification and how to incorporate
them to pandemic models; below, we summarize the main findings of this paper, enlightening the key points:
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Figure 9: The number of times more infected than reported (q˜I) vs. the observed mortality rate (ρ) for the SIRD+ψ model.
The blue, orange and green curves represent simulations using data from the Ministry of Health (q˜D = 0), 50% more deaths
(q˜D = 0.5) and 100% more deaths (q˜D = 1).
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Figure 10: Mortality rate paths using the number of times more infected than reported (q˜I) versus the number of times more
deaths than reported (q˜D) for the SIRASD+ψ model.
Figure 11: Symptomatic and overall mortality rate over time for the SIRASD+ψ model.
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• Since the spread of the SARS-CoV-2 virus is inherently complex and varies according to multiple
factors (some which are possibly unmodelled and external), exact forecasts of the pandemic dynamics
are not viable. Therefore, the correct procedure should be based on a recurrent model tuning (via
identification), always taking into account the uncertainty margins. This measure would allow to
present more coherent forecasts as time goes, since the uncertainty margins tend to decrease as the
pandemic ceases (and as more testing is done). We remark that, in this paper, the uncertainty margins
are assumed constant along the forecast horizons in order to tune/estimate the model parameters. In
future works, the Authors plan in exploring the possible differences obtained when implying a dynamic
behaviour for the uncertainty margins (asymptotic and decreasing).
• The simulation forecasts indicate that the amount of uncertainty influences directly on the date of the
infection peak, on the number of deaths and on the mortality rate of the decease.
Higher levels of infection uncertainty anticipates the infected peak in time. Considering no death
uncertainty, the symptomatic peak at July 31, 2020 for q˜I = 7 is anticipated to July 3, 2020 for
q˜I = 30 (see Table 3), almost a month difference. This is followed by the corresponding decrease
(increase) in the peak amplitude of symptomatic (asymptomatic) individuals.
Higher levels of death uncertainty cause increases in the observed and true mortality rates. Considering
a fixed amount of infected uncertainty (qI or q˜I is constant), the number of deaths and the mortality
rate are higher if the death uncertainty is higher (see Figures 8 and 11). Also, considering a fixed
amount of death uncertainty (qD or q˜D is constant), the number of deaths and the mortality rate are
lower if the infected uncertainty is higher.
Furthermore, there is a direct relationship between the uncertainty level and the observed mortality
rates, which are in fact time-varying (Figure 11). The instant mortality rates are calculated using the
number of deaths and the cumulative number of infected, while the true mortality rate is its asymptotic
value. So depending in which stage of the epidemic we are at, estimations using population samples
could vary, not only by the method itself, but also due to the natural evolution of the proportions of
infected and deaths.
• Higher uncertainty levels of asymptomatic individuals causes a decrease in the epidemiological param-
eters βA and γA (Table 7). There are two possible interpretations for the transmission parameter: (i)
according to (Kemper, 1978), asymptomatic individuals presumably have more contacts, since they
do not have any symptoms and, therefore, do not do a self-induced quarantine; and (ii) according
to (Robinson & Stilianakis, 2013), the transmission of the infection is more readily on symptomatic
individuals due to physical signs of illness (coughing, sneezing, etc.), which outweighs this first factor.
Since βA > βS , our results support the first hypothesis.
That said, the transmission parameter βA is approximately 0.47 for q˜I = 5 and 0.45 for q˜I = 30,
corresponding to 2.3% to 6.8% higher than the symptomatic transmission parameter12, meaning that
asymptomatic individuals are more likely to transmit the disease since the greater number of contacts
over-weights the probability of transmitting the disease due to physical signs of illness.
The duration of the infection 1/γA is approximately 1/0.21 ≈ 4.8 days for q˜I = 5 and 1/0.17 ≈ 5.9
days for q˜I = 30, corresponding to 12% to 28.4% less than the average time to recovery of symptomatic
individuals (1/γS = 1/0.15 ≈ 6.7 days), meaning that the infectious period of the asymptomatic is
smaller than the symptomatic one. This is consistent with other pandemic, such as the H1N1 pandemic
(see Table 1 from Robinson & Stilianakis (2013) for γA and γS , and corresponding references).
• We find that the effect of under-reporting of the number of infected and deaths is related to the true
mortality rate, which we call “COVID-19 under-reporting tripod”. Considering that there are three
variables with uncertainty (the under-reporting of infected individuals, under-reporting of deaths, and
the true mortality rate), if two of them are known (or measured empirically), the other can be inferred
12Considering βS = 0.44, then βA = 0.47 corresponds to 0.03/0.44 ≈ 6.8% and βA = 0.45 corresponds to 0.01/0.44 ≈ 2.3%.
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assuming a constant amount of uncertainty. Alternatively, if one is known, it is possible to infer a
path for the other two. This is shown in Figure 10.
This approach allows to align the observed to the true mortality rate in order to find the population
uncertainty. (Mallapaty, 2020) mentions that many studies are estimating the true mortality rate to
be in the range of 0.5-1%. Assuming that this is the true mortality rate, the number of times more
infected than reported is about: 8-16 considering the deaths reported by the Ministry of Health; 10-
20.5 considering 25% more deaths than reported; 12-24.5 considering 50% more deaths than reported;
and 15.5-30 considering 100% more deaths than reported. Alternatively, considering 9 times more
infected than reported, the true mortality rate varies from 0.87% to 1%, resulting in 0 to 13% more
deaths than reported; if we consider 12 times more deaths than reported, the true mortality rate range
is 0.67%-1%, and the death uncertainty range is 0-50%. Other analysis can be inferred directly from
Figure 10. These results are consistent with estimated and empirical findings presented in Table 1.
• We note that the level of uncertainty plays a significant role in shifting the Susceptible-Infected trans-
mission curves of the contagion. Uncertainty not only influences the effective transmission rate per
infectious contact, but also the recovery and mortality rates associated to the virus. It is possible to
make a parallel between this paper and the recent study by (Hbert-Dufresne et al., 2020), which inves-
tigates how macroscopic patterns and social reinforcement of interacting contagions through SIR-like
models; it is shown how social reinforcement can directly meddle with the contagion transmission rate
along the spread regime. The results point to very similar behaviours of the SIR curves as to the
influence of the uncertainty levels. We note, nonetheless, that uncertainty also shifts and increases
the peak of these curves, which does not happen in the demonstrations presented in (Hbert-Dufresne
et al., 2020).
We must stress, once again, that the used models have a series of limitations (such as unmodelled
phenomena and disregarded transient behaviours), the available datasets are very imprecise, and also that
the forecasting / model-based prediction problem has a lot of associated sensibility: it is composed of several
coupled nonlinear differential equations, which heavily rely on initial conditions (and also contour factors
due to the time-series behaviour implied via ψ(t)). Furthermore, the pandemic dynamics may vary abruptly
if more intense health policies are adopted (or dropped) on the future. Therefore, we must recall that
the reader that the results presented in this paper are qualitative. Our intentions in showing long-term
predictions is not to provide perfect accurateness regarding the number of infection and deaths, but to
show relevant phenomena regarding the levels of uncertainty. If more testing is performed, for example, the
uncertainty levels tend to decrease and, thus, the forecast should also change. Also, if the elderly people
were to be isolated from the virus in a more effective way, we would expect to see a decrease in death rate,
even if the number of infected is increasing, since the mortality rate for this group of people is considerably
higher than for people younger than 65 years, as shown by (Perez-Saez et al., 2020).
The Authors truly hope that the proposition herein formalised can serve to help determining adequate
public health policies for Brazil.
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6. Appendix
6.1. Observed mortality rates
Times more infected (q˜I)
Mortality rate (ρ)
q˜D = 0 q˜D = 0.25 q˜D = 0.5 q˜D = 1
0 8.8569% 10.9324% 12.9481% 16.7947%
1 4.6676% 5.8437% 7.0219% 9.3818%
2 3.1651% 3.9819% 4.8088% 6.4925%
3 2.3932% 3.0183% 3.6543% 4.9602%
4 1.9233% 2.4292% 2.9457% 4.0113%
5 1.6070% 2.0318% 2.4663% 3.3658%
6 1.3798% 1.7458% 2.1207% 2.8988%
7 1.2086% 1.5300% 1.8597% 2.5450%
8 1.0750% 1.3614% 1.6555% 2.2677%
9 0.9678% 1.2261% 1.4915% 2.0446%
10 0.8799% 1.1151% 1.3568% 1.8612%
11 0.8066% 1.0224% 1.2444% 1.7079%
12 0.7444% 0.9438% 1.1490% 1.5777%
13 0.6911% 0.8764% 1.0671% 1.4658%
14 0.6447% 0.8177% 0.9958% 1.3683%
15 0.6042% 0.7664% 0.9335% 1.2830%
16 0.5684% 0.7211% 0.8784% 1.2077%
17 0.5365% 0.6807% 0.8293% 1.1405%
18 0.5080% 0.6446% 0.7854% 1.0803%
19 0.4824% 0.6121% 0.7459% 1.0263%
20 0.4591% 0.5826% 0.7100% 0.9771%
21 0.4380% 0.5559% 0.6775% 0.9325%
22 0.4187% 0.5315% 0.6478% 0.8917%
23 0.4010% 0.5090% 0.6204% 0.8542%
24 0.3847% 0.4884% 0.5953% 0.8198%
25 0.3697% 0.4693% 0.5721% 0.7879%
26 0.3557% 0.4517% 0.5507% 0.7585%
27 0.3428% 0.4353% 0.5307% 0.7311%
28 0.3307% 0.4200% 0.5121% 0.7055%
29 0.3195% 0.4057% 0.4948% 0.6817%
30 0.3090% 0.3924% 0.4785% 0.6594%
Table 4: Observed mortality rates (ρ) for different simulations of the SIRD+ψ model under infected (q˜I) and death (q˜D)
uncertainty.
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Times more infected (q˜I)
Mortality rate (ρ)
q˜D = 0 q˜D = 0.25 q˜D = 0.5 q˜D = 1
0.1 7.9411% 9.8027% 11.6102% 15.2003%
1 4.2743% 5.3126% 6.3393% 8.3585%
2 2.8489% 3.5411% 4.2255% 5.5716%
3 2.1364% 2.6554% 3.1687% 4.1782%
4 1.7089% 2.1241% 2.5346% 3.3422%
5 1.4239% 1.7698% 2.1119% 2.7848%
6 1.2203% 1.5168% 1.8100% 2.3867%
7 1.0676% 1.3270% 1.5836% 2.0881%
8 0.9489% 1.1794% 1.4074% 1.8559%
9 0.8539% 1.0614% 1.2665% 1.6701%
10 0.7761% 0.9647% 1.1513% 1.5181%
11 0.7114% 0.8842% 1.0552% 1.3915%
12 0.6566% 0.8161% 0.9739% 1.2843%
13 0.6096% 0.7578% 0.9043% 1.1924%
14 0.5689% 0.7072% 0.8439% 1.1128%
15 0.5333% 0.6629% 0.7910% 1.0431%
16 0.5018% 0.6238% 0.7444% 0.9817%
17 0.4739% 0.5891% 0.7030% 0.9270%
18 0.4489% 0.5580% 0.6659% 0.8781%
19 0.4264% 0.5300% 0.6325% 0.8341%
20 0.4061% 0.5048% 0.6024% 0.7943%
21 0.3876% 0.4818% 0.5749% 0.7581%
22 0.3707% 0.4608% 0.5499% 0.7251%
23 0.3552% 0.4415% 0.5269% 0.6948%
24 0.3409% 0.4238% 0.5058% 0.6670%
25 0.3278% 0.4075% 0.4862% 0.6412%
26 0.3156% 0.3923% 0.4682% 0.6174%
27 0.3043% 0.3783% 0.4514% 0.5953%
28 0.2938% 0.3652% 0.4358% 0.5747%
29 0.2840% 0.3530% 0.4212% 0.5555%
30 0.2749% 0.3416% 0.4076% 0.5375%
Table 5: Observed mortality rates (ρ = p ρS) for different simulations of the SIRASD+ψ model under infected (q˜I) and death
(q˜D) uncertainty.
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6.2. Simulation parameters
Number of deaths provided by the Ministry of Health (q˜D = 0)
q˜I β ρ
0 0.441881 0.088569
5 0.424779 0.016070
10 0.423526 0.008799
15 0.423275 0.006042
20 0.423254 0.004591
25 0.423415 0.003697
30 0.423607 0.003090
25% more deaths (q˜D = 0.25)
q˜I β ρ
0 0.447062 0.109324
5 0.425398 0.020318
10 0.423706 0.011151
15 0.423286 0.007664
20 0.423174 0.005826
25 0.423276 0.004693
30 0.423427 0.003924
50% more deaths (q˜D = 0.5)
q˜I β ρ
0 0.452330 0.129481
5 0.426041 0.024663
10 0.423897 0.013568
15 0.423304 0.009335
20 0.423098 0.007100
25 0.423139 0.005721
30 0.423247 0.004785
100% more deaths (q˜D = 1)
q˜I β ρ
0 0.463086 0.167947
5 0.427405 0.033658
10 0.424317 0.018612
15 0.423359 0.012830
20 0.422956 0.009771
25 0.422871 0.007879
30 0.422889 0.006594
Table 6: Estimated values of the epidemiological parameters for the SIRD+ψ model. We used γ = 0.150876 provided by
(Bastos & Cajueiro, 2020), and α = 0.186353 and ψ∞ = 0.494027 (calculated with the data from the Ministry of Health,
without any uncertainty) in all simulations.
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Number of deaths provided by the Ministry of Health (q˜D = 0)
q˜I βA βS γA γS ρ p
0.1 0.596899 0.441881 0.286665 0.150876 0.087352 0.909091
1 0.495901 0.441881 0.206414 0.150876 0.085485 0.500000
5 0.469934 0.441881 0.186263 0.150876 0.085431 0.166667
10 0.464844 0.441881 0.182116 0.150876 0.085377 0.090909
15 0.462002 0.441881 0.179598 0.150876 0.085324 0.062500
20 0.459022 0.441881 0.177151 0.150876 0.085274 0.047619
25 0.456489 0.441881 0.174976 0.150876 0.085225 0.038462
30 0.453604 0.441881 0.172562 0.150876 0.085208 0.032258
25% more deaths (q˜D = 0.5)
q˜I βA βS γA γS ρ p
0.1 0.595876 0.447062 0.286665 0.150876 0.107830 0.909091
1 0.488607 0.447062 0.200907 0.150876 0.106252 0.500000
5 0.468361 0.447062 0.185085 0.150876 0.106190 0.166667
10 0.463912 0.447062 0.181421 0.150876 0.106122 0.090909
15 0.461257 0.447062 0.179043 0.150876 0.106060 0.062500
20 0.458375 0.447062 0.176669 0.150876 0.105999 0.047619
25 0.455899 0.447062 0.174537 0.150876 0.105939 0.038462
30 0.453410 0.447062 0.172425 0.150876 0.105882 0.032258
50% more deaths (q˜D = 0.5)
q˜I βA βS γA γS ρ p
0.1 0.594797 0.452330 0.286665 0.150876 0.127712 0.909091
1 0.481588 0.452330 0.195552 0.150876 0.126786 0.500000
5 0.466812 0.452330 0.183913 0.150876 0.126715 0.166667
10 0.462976 0.452330 0.180717 0.150876 0.126638 0.090909
15 0.460515 0.452330 0.178486 0.150876 0.126566 0.062500
20 0.457731 0.452330 0.176187 0.150876 0.126494 0.047619
25 0.455307 0.452330 0.174095 0.150876 0.126425 0.038462
30 0.452822 0.452330 0.171994 0.150876 0.126358 0.032258
100% more deaths (q˜D = 1)
q˜I βA βS γA γS ρ p
0.1 0.496673 0.463086 0.208421 0.150876 0.167203 0.909091
1 0.468433 0.463086 0.185298 0.150876 0.167170 0.500000
5 0.463762 0.463086 0.181556 0.150876 0.167088 0.166667
10 0.461252 0.463086 0.179352 0.150876 0.166994 0.090909
15 0.459041 0.463086 0.177363 0.150876 0.166901 0.062500
20 0.456445 0.463086 0.175211 0.150876 0.166811 0.047619
25 0.454125 0.463086 0.173201 0.150876 0.166724 0.038462
30 0.451705 0.463086 0.171152 0.150876 0.166639 0.032258
Table 7: Estimated values of the epidemiological parameters for the SIRASD+ψ model. We used α = 0.186353 and ψ∞ =
0.494027 in all simulations.
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